Range Low Price High Price Comment
30 days $2.05 $2.64 Thursday, 28th Mar 2024 CHRS stock ended at $2.39. This is 1.24% less than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 6.36% from a day low at $2.36 to a day high of $2.51.
90 days $1.93 $3.70
52 weeks $1.44 $8.65

Historical Coherus BioSciences prices

Date Open High Low Close Volume
2020-08-28 $19.16 $19.40 $19.02 $19.38 471 989
2020-08-27 $18.93 $19.17 $18.76 $18.97 577 635
2020-08-26 $18.67 $19.26 $18.67 $18.92 503 377
2020-08-25 $19.17 $19.30 $18.87 $19.22 336 986
2020-08-24 $19.00 $19.20 $18.43 $19.08 609 625
2020-08-21 $19.42 $19.57 $18.79 $19.00 957 644
2020-08-20 $19.75 $20.20 $19.13 $19.45 1 025 924
2020-08-19 $19.43 $20.15 $19.43 $19.85 969 310
2020-08-18 $19.97 $20.28 $19.45 $19.50 1 141 663
2020-08-17 $19.08 $20.03 $19.06 $19.89 915 313
2020-08-14 $19.43 $19.57 $18.94 $19.07 473 939
2020-08-13 $18.80 $19.55 $18.80 $19.46 916 584
2020-08-12 $18.82 $19.11 $18.45 $18.90 888 254
2020-08-11 $18.76 $19.26 $18.51 $18.76 1 048 380
2020-08-10 $19.88 $20.06 $18.19 $18.75 1 161 100
2020-08-07 $19.95 $20.73 $18.47 $19.63 4 113 479
2020-08-06 $18.26 $18.27 $17.35 $17.41 848 636
2020-08-05 $18.13 $18.32 $17.78 $18.17 989 380
2020-08-04 $18.19 $18.35 $17.77 $17.90 694 581
2020-08-03 $17.62 $18.42 $17.45 $18.23 759 129
2020-07-31 $18.08 $18.30 $17.16 $17.59 1 053 104
2020-07-30 $17.99 $18.41 $17.82 $18.15 836 698
2020-07-29 $18.66 $18.75 $17.79 $18.19 1 105 732
2020-07-28 $18.85 $19.29 $18.33 $18.55 817 394
2020-07-27 $18.47 $18.97 $18.28 $18.92 620 536
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT